Literature DB >> 30391047

Metabolic syndrome among adults living with sickle cell disease.

Foluso Joy Ogunsile1, Shawn M Bediako2, Julie Nelson3, Cody Cichowitz4, Tiffany Yu5, C Patrick Carroll4, Kerry Stewart4, Rakhi Naik4, Carlton Haywood4, Sophie Lanzkron4.   

Abstract

Metabolic syndrome (MetS) is a key risk factor for cardiovascular disease (CVD) incidence and all-cause mortality. MetS prevalence among adults with sickle cell disease (SCD) is not well known. We report initial findings from a cross-sectional study that examined MetS risk factors within a cohort of adults living with SCD. 50 adult SCD participants (ages 21-66 years; 72% female) completed demographic and health behavior surveys, health-related family and personal histories, and anthropometric and laboratory measurements. Descriptive and inferential statistics were used to summarize and compare CVD risk factors, stratified in separate analyses by SCD genotype and sex. Triglyceride, blood pressure, and fasting glucose levels were within normal limits. 78% of the cohort reported moderate to high physical activity. However, 46% of this cohort was overweight and dietary saturated fat intake exceeded both the national average (11%) and US Dietary Guidelines (<10%). 14.3% of the cohort fulfilled criteria for MetS with large waist circumference and reduced HDL levels prominently accounting for this status. We evaluated the prevalence of MetS in a cohort of adults living with SCD. Our findings suggest that increased attention to eating habits and physical activity may generate new approaches for decreasing cardiovascular morbidity in SCD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metabolic syndrome; Obesity; Sickle cell disease

Mesh:

Substances:

Year:  2018        PMID: 30391047     DOI: 10.1016/j.bcmd.2018.10.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  3 in total

1.  Hemoglobin A1c and fructosamine correlate in a patient with sickle cell disease and diabetes on chronic transfusion therapy.

Authors:  Ashley McLean; Frances Wright; Neal deJong; Sarah Skinner; Ceila E Loughlin; Amy Levenson; Marcus A Carden
Journal:  Pediatr Blood Cancer       Date:  2020-07-03       Impact factor: 3.167

2.  Acacia Senegal (Gum Arabic) Supplementation Modulate Lipid Profile and Ameliorated Dyslipidemia among Sickle Cell Anemia Patients.

Authors:  Lamis Kaddam; Imad Fadl-Elmula; Omer Ali Eisawi; Haydar Awad Abdelrazig; Amal M Saeed
Journal:  J Lipids       Date:  2019-06-18

Review 3.  Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.

Authors:  Katherine C Wood; Mark T Gladwin; Adam C Straub
Journal:  Heart       Date:  2019-12-10       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.